Immunomodulating activity of inhalations of ultra-low doses of alkylating drug melphalan for severe bronchial asthma treatment

K. A. Zykov, A. L. Pukhalsky, T. I. Grishina, A. V. Rvatcheva, E. I. Sokolov (Moscow, Russia)

Source: Annual Congress 2004 - Biological markers in diagnosis, monitoring and treatment of respiratory disorders
Session: Biological markers in diagnosis, monitoring and treatment of respiratory disorders
Session type: Thematic Poster Session
Number: 3564
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. A. Zykov, A. L. Pukhalsky, T. I. Grishina, A. V. Rvatcheva, E. I. Sokolov (Moscow, Russia). Immunomodulating activity of inhalations of ultra-low doses of alkylating drug melphalan for severe bronchial asthma treatment. Eur Respir J 2004; 24: Suppl. 48, 3564

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Inhalations of ultra-low doses of alkylating drug for the treatment of steroid-dependant asthma: anti-inflammatory effect of therapy
Source: Eur Respir J 2001; 18: Suppl. 33, 266s
Year: 2001

New method of treatment of steroid-dependant asthma with inhalations of ultra-low doses of alkylating drug: clinical results
Source: Eur Respir J 2001; 18: Suppl. 33, 50s
Year: 2001

Gaining the control over severe asthma with the inhalations of very low doses of alkylating drug
Source: Eur Respir J 2002; 20: Suppl. 38, 54s
Year: 2002

The inhalations of low-doses of cyclosporin A for bronchial asthma treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 49s
Year: 2005

Treatment of bronchial asthma with inhalations of low doses of cyclosporin A
Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches
Year: 2009


Response of children with bronchial asthma to combined therapy with an oral immunostimulating drug and antileukotrienes
Source: Eur Respir J 2005; 26: Suppl. 49, 159s
Year: 2005

Efficacy of systemic corticosteroids in refractory asthmatics showing no bronchial reversibility with high-dose inhaled corticosteroids or β2 agonist inhalation
Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases
Year: 2010


Oral steroid-sparing effect of high-dose inhaled corticosteroids in asthma
Source: Eur Respir J, 55 (1) 1901147; 10.1183/13993003.01147-2019
Year: 2020



The inhalation of very low doses of alkylating drug as the treatment of severe asthma: five-year results
Source: Eur Respir J 2002; 20: Suppl. 38, 54s
Year: 2002

Concomitant use of low-dose inhaled corticosteroids and a long-acting bronchodilatator visavi doubling the dose of inhaled corticosterod in asthma patients
Source: Eur Respir J 2001; 18: Suppl. 33, 98s
Year: 2001

Efficacy of short-term high dose predonisolone therapy in acute exacerbation of bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 71s
Year: 2001

Cardioprotective effects of inhaled corticosteroid-containing combination therapy in COPD
Source: Eur Respir J, 53 (2) 1802420; 10.1183/13993003.02420-2018
Year: 2019



Efficacy of low dose theophylline and inhaled corticosteroids in smokers with asthma
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008


The effects of nebulised bronchodilators and corticosteroids treatment compared with inhaled drug therapy for moderate COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 290s
Year: 2004

Adding slow-released theophyllne to inhaled corticosteroids in the treatment of mild persistent asthma
Source: Annual Congress 2007 - Recent advances in our understanding of the treatment of asthma
Year: 2007


Anti-inflammatory therapy COPD: fenspiride and(or) theophylline versus inhaled corticosteroids?
Source: Annual Congress 2007 - Treatment of COPD
Year: 2007


Low adherence to inhaled corticosteroids/long-acting ß2-agonists and biologic treatment in severe asthmatics
Source: ERJ Open Res, 6 (2) 00017-2020; 10.1183/23120541.00017-2020
Year: 2020



Efficacy and safety of high-dose inhaled corticosteroids therapy in children with asthma
Source: Annual Congress 2010 - Allergy and risk factors in paediatrics
Year: 2010


High doses of N-acetylcysteine alone or in combination with inhaled corticosteroids and oxidative stress in patients with COPD
Source: Annual Congress 2011 - Novel mechanisms in lung injury
Year: 2011

Efficacy of inhaled ciclesonide compared with oral prednisolone in the treatment of asthma exacerbations
Source: Eur Respir J 2006; 28: Suppl. 50, 206s
Year: 2006